Investors believe it's a $1-billion-to-$3-billion-a-year market, but hard figures are elusive, because most peptides are sold on the quasi-legal gray market
The meaningful benefits shown by Jardiance in the Phase III EMPA-KIDNEY trial are welcome news for adults living with CKD in [the U.S.], Katherine Tuttle, executive director for research at Providence Inland Northwest Health, regional principal investigator for the Institute of Translational Health Sciences, professor of medicine at the University of Washington, and a steering committee member for the trial, said in a prepared statement
The extensive research supporting GHK-Cus efficacy, combined with its excellent safety profile, makes it an invaluable addition to any comprehensive anti-aging strategy
Talk to a Specialist Want the Full Scientific Evidence Review
This dose is set to keep Vitamin B12 levels in the body after the initial doses fix the deficiency
Copper peptides support existing follicles and may improve transplant results when used as adjunctive therapy